There are 70 coronavirus vaccines in development globally, with three candidates already being tested in human trials, according to the World Health Organization (WHO), as drugmakers race to find a cure for the deadly pathogen.
The furthest along in the clinical process is an experimental vaccine developed by Hong Kong-listed CanSino Biologics Inc. and the Beijing Institute of Biotechnology, which is in phase 2. The other two being tested on humans are treatments developed separately by US drugmakers Moderna and Inovio Pharmaceuticals , according to a WHO document.
Progress is occurring at unprecedented speed in developing vaccines as the infectious pathogen